PT1414453E - Polimorfo de cloridrato de fexofenadina - Google Patents
Polimorfo de cloridrato de fexofenadina Download PDFInfo
- Publication number
- PT1414453E PT1414453E PT02751479T PT02751479T PT1414453E PT 1414453 E PT1414453 E PT 1414453E PT 02751479 T PT02751479 T PT 02751479T PT 02751479 T PT02751479 T PT 02751479T PT 1414453 E PT1414453 E PT 1414453E
- Authority
- PT
- Portugal
- Prior art keywords
- fexofenadine hydrochloride
- hydrochloride polymorph
- polymorph
- fexofenadine
- bronchodilator
- Prior art date
Links
- RRJFVPUCXDGFJB-UHFFFAOYSA-N Fexofenadine hydrochloride Chemical compound Cl.C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RRJFVPUCXDGFJB-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000354 fexofenadine hydrochloride Drugs 0.000 title abstract 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000043 antiallergic agent Substances 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01610081 | 2001-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1414453E true PT1414453E (pt) | 2008-05-29 |
Family
ID=8183555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02751479T PT1414453E (pt) | 2001-07-31 | 2002-07-29 | Polimorfo de cloridrato de fexofenadina |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20040248935A1 (pt) |
| EP (1) | EP1414453B1 (pt) |
| AT (1) | ATE389405T1 (pt) |
| DE (1) | DE60225694T2 (pt) |
| ES (1) | ES2301662T3 (pt) |
| PT (1) | PT1414453E (pt) |
| WO (1) | WO2003011295A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20030900A2 (en) * | 2001-04-09 | 2005-08-31 | Teva Pharmaceutical Industries Ltd. | Polymorphs of fexofenadine hydrochloride |
| JP2005532356A (ja) | 2002-06-10 | 2005-10-27 | テバ ファーマシューティカル インダストリーズ リミティド | 塩酸フェキソフェナジンの多型体ｘｖｉ |
| GB0319935D0 (en) | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
| KR20070007196A (ko) * | 2004-04-26 | 2007-01-12 | 테바 파마슈티컬 인더스트리즈 리미티드 | 펙소페나딘 히드로클로라이드의 결정형 및 이의 제조 방법 |
| ITMI20041143A1 (it) * | 2004-06-08 | 2004-09-08 | Dipharma Spa | Polimorfi di fexofenadina e procedimento per la loro preparazione |
| WO2007052310A2 (en) * | 2005-11-03 | 2007-05-10 | Morepen Laboratories Limited | Polymorphs of fexofenadine hydrochloride and process for their preparation |
| DOP2006000274A (es) | 2005-12-14 | 2007-10-15 | Sanofi Aventis Us Llc | Formulación de suspensión de fexofenadina |
| MX2009000320A (es) * | 2006-07-11 | 2009-06-05 | Mutual Pharmaceutical Co | Formulaciones de liberacion controlada. |
| US20090306135A1 (en) | 2008-03-24 | 2009-12-10 | Mukesh Kumar Sharma | Stable amorphous fexofenadine hydrochloride |
| US20100183717A1 (en) * | 2009-01-16 | 2010-07-22 | Kristin Arnold | Controlled-release formulations |
| US9216955B2 (en) | 2010-06-15 | 2015-12-22 | Chemelectiva S.R.L. | Polymorphic form of Fexofenadine hydrochloride, intermediates and process for its preparation |
| CN104072402B (zh) * | 2014-07-16 | 2016-08-17 | 昆山龙灯瑞迪制药有限公司 | 一种新结晶形式的盐酸非索非那定化合物及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1907967B (zh) * | 1994-05-18 | 2012-07-04 | 安万特萨博Ⅱ有限公司 | 抗组胺哌啶衍生物,其多晶形物和假同晶物的无水和水合物形式的制备方法 |
| FI973518A7 (fi) * | 1995-02-28 | 1997-08-27 | Aventisub Ii Inc | Piperidinoalkanoliyhdistettä tai sen farmaseuttisesti hyväksyttävää suolaa sisltävä farmaseuttinen koostumus kiinteässä yksikköannosmuodossa |
-
2002
- 2002-07-29 US US10/485,391 patent/US20040248935A1/en not_active Abandoned
- 2002-07-29 WO PCT/IB2002/002954 patent/WO2003011295A1/en active IP Right Grant
- 2002-07-29 PT PT02751479T patent/PT1414453E/pt unknown
- 2002-07-29 EP EP02751479A patent/EP1414453B1/en not_active Expired - Lifetime
- 2002-07-29 DE DE60225694T patent/DE60225694T2/de not_active Expired - Fee Related
- 2002-07-29 ES ES02751479T patent/ES2301662T3/es not_active Expired - Lifetime
- 2002-07-29 AT AT02751479T patent/ATE389405T1/de not_active IP Right Cessation
-
2009
- 2009-09-18 US US12/562,725 patent/US20100010229A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003011295A1 (en) | 2003-02-13 |
| ATE389405T1 (de) | 2008-04-15 |
| DE60225694D1 (de) | 2008-04-30 |
| ES2301662T3 (es) | 2008-07-01 |
| DE60225694T2 (de) | 2008-06-26 |
| US20040248935A1 (en) | 2004-12-09 |
| WO2003011295B1 (en) | 2003-04-03 |
| EP1414453A1 (en) | 2004-05-06 |
| US20100010229A1 (en) | 2010-01-14 |
| EP1414453B1 (en) | 2008-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU92880I2 (fr) | Evérolimus ou un sel pharmaceutiquement acceptablequi en dérive (afinitor) | |
| GB0124627D0 (en) | Novel compounds | |
| AU2003248872A8 (en) | Hiv integrase inhibitors | |
| MXPA05009367A (es) | Antagonistas del receptor opioide. | |
| DE60112974D1 (en) | Carbolinderivate | |
| EP1549315A4 (en) | DIHYDROXYPYRIDOPYRAZINE-1,6-DION COMPOUNDS AS HIV INTEGRASE INHIBITORS | |
| WO2005110410A3 (en) | Kinase inhibitors as therapeutic agents | |
| YU64303A (sh) | N-supstituisani nearil-heterociklični antagonisti nmda/nr2b | |
| AU2003239389A1 (en) | Opioid receptor antagonists | |
| MXPA03010761A (es) | Combinaciones farmaceuticas. | |
| WO2001056573A8 (en) | Use of cox-2 inhibitors as gastroprokinetics | |
| PT1414453E (pt) | Polimorfo de cloridrato de fexofenadina | |
| AU2003216620A1 (en) | Method of stabilizing bupropion hydrochloride tablets | |
| PL370664A1 (en) | Hiv integrase inhibitors | |
| WO2002053519A3 (en) | Hydrophobic polyamine analogs and methods for their use | |
| IL166483A0 (en) | Pharmaceutical compositions containing ciclesonideand an antihistamine | |
| IL172542A0 (en) | 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide | |
| WO2005065047A3 (en) | Stable oral composition containing desloratadine | |
| IL166730A0 (en) | N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-Ä1,3,4-oxadiazol-2-ylÜphenyl)pyridine-3-sulphonamide as an anticancer agent | |
| AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
| AU2003280065A1 (en) | Bupropion hydrochloride solid dosage forms | |
| TW200514553A (en) | Therapeutic agent for hepatitis C | |
| SE0102809D0 (sv) | Novel compounds | |
| ECSP034708A (es) | Nueva sal de benzoilguanidina | |
| DK1776366T3 (da) | Immunomodulerende oxopyrazolocinnoliner som CD80-inhibitorer |